1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow abelacimab: new trials by email Literature Review of abelacimab trials Research Report on abelacimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation Abelacimab, Rivaroxaban - Atrial Fibrillation (AF), Stroke | Phase 2 | Active not recruiting | Anthos Therapeutics, Inc. | 1287 | 2021-02-02 | 2025-11-06 |
Atrial Fibrillation (1) · Stroke (1)
Canada (1) · Czechia (1) · Hungary (1) · Poland (1) · South Korea (1) · Taiwan (1) · United States (1)